DiaMedica Therapeutics Inc.
DMAC
$3.77
-$0.08-2.08%
NASDAQ
03/31/2025 | 12/31/2024 | ||||
---|---|---|---|---|---|
Revenue | -- | -- | |||
Total Other Revenue | -- | -- | |||
Total Revenue | -- | -- | |||
Cost of Revenue | -- | -- | |||
Gross Profit | -- | -- | |||
SG&A Expenses | 27.66% | 2.58% | |||
Depreciation & Amortization | -- | -- | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | -3.27% | 22.32% | |||
Operating Income | 3.27% | -22.32% | |||
Income Before Tax | 2.41% | -25.91% | |||
Income Tax Expenses | -33.33% | 28.57% | |||
Earnings from Continuing Operations | 2.44% | -25.92% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | 2.44% | -25.92% | |||
EBIT | 3.27% | -22.32% | |||
EBITDA | 3.27% | -22.33% | |||
EPS Basic | 2.55% | -25.75% | |||
Normalized Basic EPS | 2.52% | -25.76% | |||
EPS Diluted | 2.55% | -25.75% | |||
Normalized Diluted EPS | 2.52% | -25.76% | |||
Average Basic Shares Outstanding | 0.09% | 0.13% | |||
Average Diluted Shares Outstanding | 0.09% | 0.13% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |